Production (Stage)
Sensei Biotherapeutics, Inc.
SNSE
$0.3056
$0.01063.59%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -40.89% | -37.14% | -34.73% | -33.68% | -39.19% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -51.65% | -59.42% | -32.49% | -23.47% | -28.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 63.57% | -63.08% | -74.53% | -43.65% | -40.75% |
| Total Current Assets | -40.76% | -37.65% | -34.86% | -33.46% | -38.92% |
|
|
|||||
| Total Current Assets | -40.76% | -37.65% | -34.86% | -33.46% | -38.92% |
| Net Property, Plant & Equipment | -59.73% | -51.92% | -34.48% | -31.54% | -31.04% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -72.09% | -44.19% | 1.16% | 1.16% | 6.17% |
| Total Assets | -42.61% | -39.01% | -34.78% | -33.25% | -38.21% |
|
|
|||||
| Total Accounts Payable | -81.95% | -57.42% | -38.54% | -29.33% | -57.58% |
| Total Accrued Expenses | 411.48% | 13.24% | 21.77% | 18.60% | -11.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -13.20% | -4.96% | 1.16% | 6.14% | 8.45% |
| Total Finance Division Other Current Liabilities | -- | -28.96% | -- | -- | -- |
| Total Other Current Liabilities | -- | -28.96% | -- | -- | -- |
| Total Current Liabilities | 4.75% | -3.46% | -12.61% | -7.62% | -34.17% |
|
|
|||||
| Total Current Liabilities | 4.75% | -3.46% | -12.61% | -7.62% | -34.17% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -66.56% | -59.49% | -53.40% | -47.66% | -42.17% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -6.94% | 100.00% |
| Total Liabilities | -23.54% | -26.42% | -29.86% | -26.71% | -37.16% |
|
|
|||||
| Common Stock & APIC | 0.81% | 1.16% | 1.41% | 0.74% | -1.69% |
| Retained Earnings | -12.10% | -13.00% | -13.28% | -13.65% | -15.35% |
| Treasury Stock & Other | 95.62% | 93.78% | 103.48% | 83.06% | 83.35% |
| Total Common Equity | -45.30% | -40.85% | -35.52% | -34.10% | -38.35% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -45.30% | -40.85% | -35.52% | -34.10% | -38.35% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -45.30% | -40.85% | -35.52% | -34.10% | -38.35% |
|
|
|||||